查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041724

神經血管栓塞市場預測至2034年：按產品、手術、最終用戶和地區分類的全球分析

Neurovascular Embolization Market Forecasts to 2034 - Global Analysis By Product, Procedure (Arteriovenous Malformation Embolization, Aneurysm Coiling and Embolization and Other Procedures), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球神經血管栓塞市場規模將達到 19 億美元，並在預測期內以 8.4% 的複合年成長率成長，到 2034 年將達到 36 億美元。

神經血管栓塞術是一種用於治療影響腦部和神經系統血管的各種疾病的醫療程序。在該程序中，醫生會將栓塞劑（例如顆粒、彈簧圈或液體）有意注入血管，以阻斷或減少流向目標區域的血流，從而治療異常的血管結構。此外，透過阻斷或減少流向受影響血管的血流，神經血管栓塞術有助於緩解症狀、防止進一步損傷並促進整體血管穩定性。

據腦動脈瘤基金會稱，美國約有 670 萬人患有未破裂的腦動脈瘤，每年每 10 萬人中有 8 至 10 例破裂。

醫療基礎設施擴建

醫療基礎設施的擴建促進了醫療機構、行業相關人員和監管機構之間的合作，從而推動了研發工作。這種擴張不僅有助於應對日益嚴重的神經血管疾病負擔，還能實現及時診斷和介入。此外，這種合作環境支持栓塞材料、輸送系統和技術的持續改進，從而推動神經血管栓塞領域的整體發展。

缺乏意識和教育

大眾對神經血管栓塞術的認知度低會導致此手術使用率不足，進而可能促使患者尋求其他治療方案。缺乏公眾宣傳宣傳活動和相關資訊會導致診斷和治療延誤。此外，神經血管栓塞術的複雜性以及所需的專業技能也可能成為其廣泛應用的障礙，從而阻礙市場擴張。

技術進步

栓塞材料、輸送系統和影像技術的進步與創新顯著提高了神經血管栓塞術的準確性、安全性和有效性。先進的輸送系統，包括微導管和導航工具，使介入神經放射學醫生能夠到達複雜的血管結構。此外，人工智慧 (AI) 和機器學習的融合進一步最佳化了手術圖和執行，從而改善了治療效果並縮短了手術時間，推動了市場成長。

景氣衰退

經濟景氣衰退會影響患者承擔神經血管栓塞治療費用的能力，往往導致醫療資源緊張和成本削減措施。這可能導致醫療程序資金減少，使個人難以獲得足夠的醫療保險或有限的醫療資源。此外，景氣衰退還會擾亂整個醫療保健生態系統，包括醫生的就診和轉診模式。醫生可能面臨患者數量下降或變化，阻礙市場成長。

新冠疫情的影響

新冠疫情對神經血管栓塞市場造成了多方面的負面影響。疫情擾亂了全球醫療服務，導致包括栓塞術在內的部分神經血管介入手術被推遲或取消，從而影響了手術總量。物流的挑戰也影響了醫療設備，包括神經血管栓塞術中使用的器械。此外，醫療優先事項的轉變以及醫療系統面臨的財政負擔也阻礙了該市場的成長。

在預測期內，栓塞線圈部分預計將佔據最大佔有率。

由於栓塞線圈療法專注於治療腦血管異常，預計將佔據最大的市場佔有率。這項技術透過導管將鉑金或其他生物相容性線圈直接置入血管內。這些線圈可誘導血栓形成，促進血管的自然癒合過程，同時降低破裂風險。此外，該療法在治療包括動脈瘤和動靜脈畸形在內的多種腦血管疾病方面的廣泛應用，以及持續不斷的研發投入，正在推動這一領域的快速發展。

在預測期內，動脈瘤栓塞術和栓塞術預計將呈現最高的複合年成長率。

在預測期內，動脈瘤栓塞術和栓塞術預計將呈現最高的複合年成長率。這是一種治療腦血管異常的關鍵介入手段，經由導管經由血管到達動脈瘤部位。然後將鉑金彈簧圈或其他栓塞裝置置入動脈瘤內，以促進血栓形成並防止破裂。此外，動脈瘤栓塞術和栓塞術具有微創、恢復時間短、併發症風險低等優勢，醫護人員和患者對該療法的認知度不斷提高，也推動了該市場的持續成長。

市佔率最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率，這主要得益於不斷成長的需求和醫療基礎設施的進步。神經血管栓塞術的需求不斷成長，這得益於公眾健康意識的提高、診斷能力的提升以及醫療服務覆蓋範圍的擴大。此外，醫療機構與產業相關人員之間的合作正在推動創新型栓塞材料和器材的研發和應用，從而促進了該地區的成長。

複合年成長率最高的地區：

由於人們對包括栓塞術在內的先進介入神經放射學手術的認知度不斷提高，預計歐洲在預測期內將實現最高的複合年成長率。美敦力公司 (Medtronic plc)、Penumbra 公司、MicroVention 公司和 Acandis GmbH 公司等領導企業不斷推動醫療保健系統的技術進步，並致力於改善患者的治療效果。此外，腦血管疾病（如動脈瘤和動靜脈畸形）的發病率上升也促進了該地區的市場擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球神經血管栓塞市場：依產品分類

  • 血液灌流裝置
  • 動脈瘤夾
  • 栓塞線圈
  • 液態栓塞器/系統
  • 其他產品

第6章 全球神經血管栓塞市場：依手術方式分類

  • 動靜脈畸形（AVM）栓塞術
  • 動脈瘤栓塞術
  • 其他技術

第7章 全球神經血管栓塞市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 其他最終用戶

第8章 全球神經血管栓塞市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Cerenovus
  • Penumbra Inc
  • Medtronic
  • Phenox GmbH
  • Stryker
  • Balt SAS
  • Shape Memory Medical Inc
  • Integra LifeSciences
  • B. Braun Melsungen AG
  • MicroVention Inc
  • Peter Lazic GmbH
  • Spartan Micro
Product Code: SMRC24787

According to Stratistics MRC, the Global Neurovascular Embolization Market is accounted for $1.9 billion in 2026 and is expected to reach $3.6 billion by 2034 growing at a CAGR of 8.4% during the forecast period. Neurovascular embolization is a medical procedure used to treat various conditions affecting the blood vessels of the brain and nervous system. It involves the intentional introduction of embolic agents, such as particles, coils, or liquid substances, into the blood vessels to block or reduce blood flow to targeted areas employed to treat abnormal vascular structures. Furthermore, by occluding or reducing blood flow to the affected vessels, neurovascular embolization helps to alleviate symptoms, prevent further damage, and promote overall vascular stability.

According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000.

Market Dynamics:

Driver:

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure facilitates collaborative efforts between healthcare institutions, industry stakeholders, and regulatory bodies, fostering research and development initiatives. This expansion not only addresses the growing burden of neurovascular disorders but also enables timely diagnosis and intervention. Moreover, a collaborative environment supports the continuous improvement of embolic materials, delivery systems, and procedural techniques, contributing to the overall advancement of the neurovascular embolization field.

Restraint:

Limited awareness and education

The limited awareness can lead to underutilization of neurovascular embolization, with patients being directed towards alternative treatments. Lack of public education campaigns and information dissemination about the procedure can result in delayed diagnosis and treatment. Furthermore, the complexity of neurovascular embolization and the specialized skills required to perform the procedure can be a barrier to its widespread adoption, which is impeding this market expansion.

Opportunity:

Technological advancements

The advancements in technology and innovations in embolic materials, delivery systems, and imaging technologies have significantly improved the precision, safety, and efficacy of neurovascular embolization procedures. Advanced delivery systems, including microcatheters and navigation tools, enable neurointerventionalists to reach intricate vascular structures. Furthermore, the integration of artificial intelligence (AI) and machine learning further refines procedural planning and execution, optimizing outcomes and reducing procedural times, which drive this market growth.

Threat:

Economic downturns

Economic downturns impact patients' ability to afford neurovascular embolization procedures and often face constraints and cost-cutting measures. This can lead to a reduction in funding for medical procedures, and individuals may face challenges in securing adequate health insurance coverage or may have limited resources. Additionally, economic downturns can disrupt the overall healthcare ecosystem, including physician practices and referral patterns. Physicians may experience reduced patient volumes or changes, which are hampering this market.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the neurovascular embolization market. The pandemic led to disruptions in healthcare services globally, procedures including certain neurovascular interventions like embolization, which were deferred or cancelled, impacting the overall procedural volume. Logistic challenges also impacted the availability of medical devices, including those used in neurovascular embolization. In addition, the shift in healthcare priorities and the financial strain on healthcare systems also hindered this market size.

The embolic coils segment is expected to be the largest during the forecast period

The embolic coil segment is estimated to hold the largest share due to its focus on the treatment of vascular abnormalities in the brain. This technique involves the deployment of platinum or other biocompatible coils through a catheter directly into the blood vessel. These coils induce clot formation, promoting the natural healing process and preventing the risk of rupture. In addition, it is versatile in treating cerebrovascular conditions, including aneurysms and arteriovenous malformations, coupled with ongoing research and development efforts that are boosting this segment's expansion.

The aneurysm coiling and embolization segment is expected to have the highest CAGR during the forecast period

The aneurysm coiling and embolization segment is anticipated to have highest CAGR during the forecast period. It is a crucial intervention for treating vascular abnormalities in the brain, wherein a catheter is navigated through blood vessels to the site of the aneurysm. Platinum coils or other embolic devices are then deployed into the aneurysm, promoting blood clot formation and preventing rupture. Furthermore, aneurysm coiling and embolization procedures offer reduced invasiveness, shorter recovery times, and a lower risk of complications, and rising awareness among both healthcare providers and patients contributes to the sustained growth of this market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, owing to increased demand and advancements in healthcare infrastructure. Increasing healthcare awareness, improved diagnostic capabilities, and expanding access to healthcare services have heightened the demand for neurovascular embolization procedures. Furthermore, collaborative efforts between healthcare institutions and industry players have resulted in the development and introduction of innovative embolic materials and devices, which are driving this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a growing awareness of advanced neurointerventional procedures, including embolization. Key players such as Medtronic plc, Penumbra, Inc., MicroVention, and Acandis GmbH continue to evolve technological advancements in healthcare systems, contributing to improved patient outcomes. Furthermore, increasing incidences of cerebrovascular diseases, such as aneurysms and arteriovenous, are propelling this region's expansion.

Key players in the market

Some of the key players in the Neurovascular Embolization Market include Cerenovus, Penumbra Inc, Medtronic, Phenox GmbH, Stryker, Balt SAS, Shape Memory Medical Inc, Integra LifeSciences, B. Braun Melsungen AG, MicroVention Inc, Peter Lazic GmbH and Spartan Micro.

Key Developments:

In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral(TM) Renal Denervation (RDN) System.

In February 2022, CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies,* announced the launch of EMBOGUARD(TM), a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

In June 2021, Johnson & Johnson Medical Devices Companies* announced the first patient was enrolled in the CERENOVUS-sponsored MEMBRANE study evaluating TruFill(R) n-BCA Liquid Embolic System in the embolization of middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.

In January 2020, MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED(R) (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.

Products Covered:

  • Flow Diversion Devices
  • Aneurysm Clips
  • Embolic Coils
  • Liquid Embolic Agents/Systems
  • Other Products

Procedures Covered:

  • Arteriovenous Malformation (AVM) Embolization
  • Aneurysm Coiling and Embolization
  • Other Procedures

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurovascular Embolization Market, By Product

  • 5.1 Introduction
  • 5.2 Flow Diversion Devices
  • 5.3 Aneurysm Clips
  • 5.4 Embolic Coils
  • 5.5 Liquid Embolic Agents/Systems
  • 5.6 Other Products

6 Global Neurovascular Embolization Market, By Procedure

  • 6.1 Introduction
  • 6.2 Arteriovenous Malformation (AVM) Embolization
  • 6.3 Aneurysm Coiling and Embolization
  • 6.4 Other Procedures

7 Global Neurovascular Embolization Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Neurovascular Embolization Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Cerenovus
  • 10.2 Penumbra Inc
  • 10.3 Medtronic
  • 10.4 Phenox GmbH
  • 10.5 Stryker
  • 10.6 Balt SAS
  • 10.7 Shape Memory Medical Inc
  • 10.8 Integra LifeSciences
  • 10.9 B. Braun Melsungen AG
  • 10.10 MicroVention Inc
  • 10.11 Peter Lazic GmbH
  • 10.12 Spartan Micro

List of Tables

  • Table 1 Global Neurovascular Embolization Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 4 Global Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 5 Global Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 6 Global Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 7 Global Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 8 Global Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 9 Global Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 10 Global Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 11 Global Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 12 Global Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 13 Global Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 14 Global Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 15 Global Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 16 North America Neurovascular Embolization Market Outlook, By Country (2023-2034) ($MN)
  • Table 17 North America Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 18 North America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 19 North America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 20 North America Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 21 North America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 22 North America Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 23 North America Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 24 North America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 25 North America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 26 North America Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 27 North America Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 28 North America Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 29 North America Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 30 North America Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 31 Europe Neurovascular Embolization Market Outlook, By Country (2023-2034) ($MN)
  • Table 32 Europe Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 33 Europe Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 34 Europe Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 35 Europe Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 36 Europe Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 37 Europe Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 38 Europe Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 39 Europe Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 40 Europe Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 41 Europe Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 42 Europe Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 43 Europe Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 44 Europe Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 45 Europe Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 46 Asia Pacific Neurovascular Embolization Market Outlook, By Country (2023-2034) ($MN)
  • Table 47 Asia Pacific Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 48 Asia Pacific Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 49 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 50 Asia Pacific Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 51 Asia Pacific Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 52 Asia Pacific Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 53 Asia Pacific Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 54 Asia Pacific Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 55 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 56 Asia Pacific Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 57 Asia Pacific Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 58 Asia Pacific Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 59 Asia Pacific Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 60 Asia Pacific Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 61 South America Neurovascular Embolization Market Outlook, By Country (2023-2034) ($MN)
  • Table 62 South America Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 63 South America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 64 South America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 65 South America Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 66 South America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 67 South America Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 68 South America Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 69 South America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 70 South America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 71 South America Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 72 South America Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 73 South America Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 74 South America Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 75 South America Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 76 Middle East & Africa Neurovascular Embolization Market Outlook, By Country (2023-2034) ($MN)
  • Table 77 Middle East & Africa Neurovascular Embolization Market Outlook, By Product (2023-2034) ($MN)
  • Table 78 Middle East & Africa Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2023-2034) ($MN)
  • Table 79 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Clips (2023-2034) ($MN)
  • Table 80 Middle East & Africa Neurovascular Embolization Market Outlook, By Embolic Coils (2023-2034) ($MN)
  • Table 81 Middle East & Africa Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2023-2034) ($MN)
  • Table 82 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 83 Middle East & Africa Neurovascular Embolization Market Outlook, By Procedure (2023-2034) ($MN)
  • Table 84 Middle East & Africa Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2023-2034) ($MN)
  • Table 85 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2023-2034) ($MN)
  • Table 86 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 87 Middle East & Africa Neurovascular Embolization Market Outlook, By End User (2023-2034) ($MN)
  • Table 88 Middle East & Africa Neurovascular Embolization Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 89 Middle East & Africa Neurovascular Embolization Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 90 Middle East & Africa Neurovascular Embolization Market Outlook, By Other End Users (2023-2034) ($MN)